Literature DB >> 11716766

Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of pre beta-high-density lipoproteins.

J Lie1, R de Crom, M Jauhiainen, T van Gent, R van Haperen, L Scheek, H Jansen, C Ehnholm, A van Tol.   

Abstract

High-density lipoproteins (HDLs) are considered anti-atherogenic because they mediate peripheral cell cholesterol transport to the liver for excretion and degradation. An important step in this reverse cholesterol-transport pathway is the uptake of cellular cholesterol by a specific subclass of small, lipid-poor apolipoprotein A-I particles designated pre beta-HDL. The two lipid-transfer proteins present in human plasma, cholesteryl ester transfer protein (CETP) and phospholipid transfer protein (PLTP), have both been implicated in the formation of pre beta-HDL. In order to investigate the relative contribution of each of these proteins, we used transgenic mouse models. Comparisons were made between human CETP transgenic mice (huCETPtg), human PLTP transgenic mice (huPLTPtg) and mice transgenic for both lipid-transfer proteins (huCETPtg/huPLTPtg). These animals showed elevated plasma levels of CETP activity, PLTP activity or both activities, respectively. We evaluated the generation of pre beta-HDL in mouse plasma by immunoblotting and crossed immuno-electrophoresis. Generation of pre beta-HDL was equal in huCETPtg and wild-type mice. In contrast, in huPLTPtg and huCETPtg/huPLTPtg mice, pre beta-HDL generation was 3-fold higher than in plasma from either wild-type or huCETPtg mice. Our findings demonstrate that, of the two plasma lipid-transfer proteins, PLTP rather than CETP is responsible for the generation of pre beta-HDL. These data support the hypothesis of a role for PLTP in the initial stage of reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716766      PMCID: PMC1222238          DOI: 10.1042/0264-6021:3600379

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Molecular physiology of reverse cholesterol transport.

Authors:  C J Fielding; P E Fielding
Journal:  J Lipid Res       Date:  1995-02       Impact factor: 5.922

Review 2.  High density lipoproteins and coronary heart disease.

Authors:  P J Barter; K A Rye
Journal:  Atherosclerosis       Date:  1996-03       Impact factor: 5.162

3.  Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes.

Authors:  O L Francone; L Royer; M Haghpassand
Journal:  J Lipid Res       Date:  1996-06       Impact factor: 5.922

4.  Interconversion between apolipoprotein A-I-containing lipoproteins of pre-beta and alpha electrophoretic mobilities.

Authors:  S T Kunitake; C M Mendel; L K Hennessy
Journal:  J Lipid Res       Date:  1992-12       Impact factor: 5.922

5.  Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases.

Authors:  A Barrans; X Collet; R Barbaras; B Jaspard; J Manent; C Vieu; H Chap; B Perret
Journal:  J Biol Chem       Date:  1994-04-15       Impact factor: 5.157

6.  Lipoprotein phospholipid composition and LCAT activity in nephrotic and analbuminemic rats.

Authors:  J A Joles; N Willekes-Koolschijn; L M Scheek; H A Koomans; T J Rabelink; A van Tol
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

7.  The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

Authors:  S Lusa; M Jauhiainen; J Metso; P Somerharju; C Ehnholm
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

8.  Human plasma phospholipid transfer protein causes high density lipoprotein conversion.

Authors:  M Jauhiainen; J Metso; R Pahlman; S Blomqvist; A van Tol; C Ehnholm
Journal:  J Biol Chem       Date:  1993-02-25       Impact factor: 5.157

9.  Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice.

Authors:  T Hayek; N Azrolan; R B Verdery; A Walsh; T Chajek-Shaul; L B Agellon; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene.

Authors:  T Hayek; L Masucci-Magoulas; X Jiang; A Walsh; E Rubin; J L Breslow; A R Tall
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more
  9 in total

1.  Linkage and association of phospholipid transfer protein activity to LASS4.

Authors:  Elisabeth A Rosenthal; James Ronald; Joseph Rothstein; Ramakrishnan Rajagopalan; Jane Ranchalis; G Wolfbauer; John J Albers; John D Brunzell; Arno G Motulsky; Mark J Rieder; Deborah A Nickerson; Ellen M Wijsman; Gail P Jarvik
Journal:  J Lipid Res       Date:  2011-07-13       Impact factor: 5.922

2.  Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.

Authors:  Su Duy Nguyen; Katariina Öörni; Miriam Lee-Rueckert; Tero Pihlajamaa; Jari Metso; Matti Jauhiainen; Petri T Kovanen
Journal:  J Lipid Res       Date:  2012-08-01       Impact factor: 5.922

3.  Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid.

Authors:  Norman E Miller; Waldemar L Olszewski; Hiroaki Hattori; Irina P Miller; Takeshi Kujiraoka; Tomoichiro Oka; Tadao Iwasaki; M Nazeem Nanjee
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-12-11       Impact factor: 4.310

4.  Inducible expression of phospholipid transfer protein (PLTP) in transgenic mice: acute effects of PLTP on lipoprotein metabolism.

Authors:  Matthijs Moerland; Nora Anghelescu; Hannelore Samyn; Rien van Haperen; Teus van Gent; John Strouboulis; Arie van Tol; Frank Grosveld; Rini de Crom
Journal:  Transgenic Res       Date:  2007-04-17       Impact factor: 2.788

5.  The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions.

Authors:  Bryan A Laffitte; Sean B Joseph; Mingyi Chen; Antonio Castrillo; Joyce Repa; Damien Wilpitz; David Mangelsdorf; Peter Tontonoz
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

6.  In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.

Authors:  Sheng-Ping Wang; Erin Daniels; Ying Chen; Jose Castro-Perez; Haihong Zhou; Karen O Akinsanya; Stephen F Previs; Thomas P Roddy; Douglas G Johns
Journal:  J Lipid Res       Date:  2013-07-29       Impact factor: 5.922

7.  Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis.

Authors:  Dana Bailey; Isabelle Ruel; Anouar Hafiane; Haley Cochrane; Iulia Iatan; Matti Jauhiainen; Christian Ehnholm; Larbi Krimbou; Jacques Genest
Journal:  J Lipid Res       Date:  2009-09-29       Impact factor: 5.922

Review 8.  High-density lipoproteins, reverse cholesterol transport and atherogenesis.

Authors:  Henry J Pownall; Corina Rosales; Baiba K Gillard; Antonio M Gotto
Journal:  Nat Rev Cardiol       Date:  2021-04-08       Impact factor: 32.419

9.  Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.

Authors:  Svetlana A Didichenko; Alexei V Navdaev; Alexandre M O Cukier; Andreas Gille; Patrick Schuetz; Martin O Spycher; Patrice Thérond; M John Chapman; Anatol Kontush; Samuel D Wright
Journal:  Circ Res       Date:  2016-07-19       Impact factor: 17.367

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.